MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Hosted on MSN19h
30 Products That Have Over 10,000 5-Star Reviews For A ReasonJust check out some of the before and after photos posted among the 28,000 5-star reviews! 3.A moisturizing liquid lipstick ...
Around 30% of the population suffers from dry skin, and I’m definitely among them — especially in the brutally cold winter ...
The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback